Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study

Sponsor
Fred Hutchinson Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04447313
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
398
1
2
63.8
6.2

Study Details

Study Description

Brief Summary

This phase III trial compares telephone delivered Acceptance and Commitment Therapy to standard behavioral therapy for improving weight loss in overweight or obese participants. Acceptance and Commitment Therapy focuses on increasing willingness to experience physical cravings, emotions, and thoughts while making values-guided committed behavior changes. Acceptance and Commitment Therapy may work better at improving weight loss compared to standard behavioral therapy.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey Administration
  • Behavioral: Telephone-Based Intervention
  • Behavioral: Telephone-Based Intervention
Phase 3

Detailed Description

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants receive ACT telephone coaching over the course of 12 months, calls 1-16 weekly, calls 17-23 biweekly, and calls 24-25 monthly. Call 1 is 30 minutes in duration, while calls 2-25 are each 15-20 minutes in duration.

ARM II: Participants receive SBT telephone coaching over the course of 12 months, calls 1-16 weekly, calls 17-23 biweekly, and calls 24-25 monthly. Call 1 is 30 minutes in duration, while calls 2-25 are each 15-20 minutes in duration.

Participants are followed up at 6, 12, and 24 months after randomization.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
398 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Telephone Delivered Weight Loss, Nutrition, Exercise Study (WeLNES)
Actual Study Start Date :
Mar 5, 2021
Anticipated Primary Completion Date :
Jun 30, 2025
Anticipated Study Completion Date :
Jun 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm I (ACT)

Participants receive ACT telephone coaching over the course of 12 months, calls 1-16 weekly, calls 17-23 biweekly, and calls 24-25 monthly. Call 1 is 30 minutes in duration, while calls 2-25 are each 15-20 minutes in duration.

Other: Survey Administration
Ancillary studies

Behavioral: Telephone-Based Intervention
Receive ACT telephone coaching

Active Comparator: Arm II (SBT)

Participants receive SBT telephone coaching over the course of 12 months, calls 1-16 weekly, calls 17-23 biweekly, and calls 24-25 monthly. Call 1 is 30 minutes in duration, while calls 2-25 are each 15-20 minutes in duration.

Other: Survey Administration
Ancillary studies

Behavioral: Telephone-Based Intervention
Receive SBT telephone coaching

Outcome Measures

Primary Outcome Measures

  1. 10% or more weight loss [At 12 months after randomization]

    Will be measured remotely by cellular-enabled scales. Will compare the two telephone interventions, using logistic regression.

Secondary Outcome Measures

  1. Percent weight change [At 6, 12, and 24-months post randomization]

    Will be measured remotely by cellular-enabled scales.

  2. Dietary intake [At 6, 12, and 24-months post randomization]

    Will be measured with the Fitbit smartphone app food logging feature.

  3. Physical activity [At 6, 12, and 24-months post randomization]

    Will be measured with the Fitbit Inspire mailed to participants.

  4. Trajectories of weight change [At 6, 12, and 24-months post randomization]

    Will compare between the two arms, with time as the independent variable using mixed effects modeling with linear, quadratic, and cubic effects of time.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Overweight or obese (body mass index [BMI] >= 27) but not heavier than BMI of 45.5 (measured by weight & height)

  • Wants to lose weight in the next 30 days

  • Interested in learning skills to lose weight

  • Willing to be randomly assigned to either condition

  • Resides in United States (US)

  • Has daily access to their own phone and email

  • Does not have a medical or psychiatric condition that would limit their ability to comply with the behavioral recommendations of the program or pose a risk to the participant during weight loss, including meeting criteria for binge eating disorder, and meeting criteria for severe depression (CESD >= 25), or a diagnosis of serious heart disease, diabetes, uncontrolled hypertension, or cancer without written confirmation of approval from their physician office

  • Not pregnant, planning to become pregnant or breastfeeding in the next 12 months

  • In the past 3 months changed the dosage of prescription medications that can cause a significant change in weight or appetite

  • Have not lost more than 5% of their weight in the past 6 months

  • Willing and able to read in English

  • Not participating in or planning to participate in other weight loss programs

  • Has not participated in our other ACT intervention studies

  • Does not meet criteria for combined heavy plus binge drinking

  • Has access to a Bluetooth-enabled device and Wi-Fi and/or data plan

  • Is not planning to have or has not recently had (past 12 months) bariatric surgery

  • For outcome data retention, eligibility criteria included: Willing to complete follow-up surveys, and provide email, phone, and mailing address

Exclusion Criteria:
  • The reverse of the inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fred Hutch/University of Washington Cancer Consortium Seattle Washington United States 98109

Sponsors and Collaborators

  • Fred Hutchinson Cancer Center
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

  • Principal Investigator: Jonathan B Bricker, Fred Hutch/University of Washington Cancer Consortium

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fred Hutchinson Cancer Center
ClinicalTrials.gov Identifier:
NCT04447313
Other Study ID Numbers:
  • RG1007177
  • NCI-2020-01624
  • 10404
  • R01DK124114
First Posted:
Jun 25, 2020
Last Update Posted:
Aug 15, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2022